EPIGRAL LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,307 INR | -1.94% |
|
-0.95% | +33.79% |
| Apr. 22 | Epigral's Consolidated Profit Climbs in Fiscal Q4; Shares Up 4% | MT |
| Apr. 22 | Epigral Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024 | CI |
| Sales 2022 | 15.51B 186M | Sales 2023 | 21.88B 262M | Capitalization | 39.21B 470M |
|---|---|---|---|---|---|
| Net income 2022 | 2.53B 30.32M | Net income 2023 | 3.53B 42.37M | EV / Sales 2022 | 3.23 x |
| Net Debt 2022 | 9.68B 116M | Net Debt 2023 | 8.65B 104M | EV / Sales 2023 | 2.19 x |
| P/E ratio 2022 |
16
x | P/E ratio 2023 |
11.1
x | Employees | 936 |
| Yield 2022 * |
-
| Yield 2023 |
0.53% | Free-Float | 28.59% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.94% | ||
| 1 week | -0.95% | ||
| Current month | +19.06% | ||
| 1 month | +20.37% | ||
| 3 months | +31.48% | ||
| 6 months | +45.01% | ||
| Current year | +33.79% |
1 week
1 290.00
1 443.25
1 month
1 086.001 443.25
Current year
931.601 443.25
1 year
862.051 443.25
3 years
387.101 736.00
5 years
387.101 736.00
10 years
387.101 736.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 39 | 17-05-17 | |
| Director of Finance/CFO | - | 14-05-06 | |
| Chairman | 41 | 17-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | - | |
| Chairman | 41 | 17-03-31 | |
| Director/Board Member | 37 | 16-05-09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 1,307 | -1.94% | 86,971 |
| 24-04-25 | 1,333 | -0.95% | 64,991 |
| 24-04-24 | 1,346 | -0.38% | 93,978 |
| 24-04-23 | 1,351 | -3.43% | 209,228 |
| 24-04-22 | 1,399 | +6.00% | 487,278 |
End-of-day quote NSE India S.E., April 25, 2024
More quotes
Epigral Limited, formerly Meghmani Finechem Limited, is an India-based manufacturer of essential chemicals. The Company is engaged in manufacturing and selling chlor alkali and its derivatives. It is also engaged in the trading of agrochemical products. The Company manufactures a range of products, such as chlorinated polyvinyl chloride (CPVC) resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The Companyâs products are used in alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, soaps & detergent, and other industries. The Companyâs subsidiaries include Meghmani Advanced Sciences Limited.
Sector
Commodity Chemicals
Calendar
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +33.79% | 651M | |
| +5.14% | 103B | |
| -5.63% | 63.04B | |
| +39.52% | 39.06B | |
| +12.91% | 37.58B | |
| +7.41% | 33.24B | |
| +6.85% | 19.22B | |
| +12.86% | 16.83B | |
| +7.73% | 15.03B | |
| +16.93% | 14.96B |
- Stock Market
- Equities
- EPIGRAL Stock
